Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo
Authors
Keywords
-
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 26, Issue 13, Pages 4782-4790
Publisher
Springer Science and Business Media LLC
Online
2019-09-17
DOI
10.1245/s10434-019-07800-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
- (2017) Xiaofeng Dai et al. Journal of Cancer
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential
- (2016) Piti Techavichit et al. BMC CANCER
- Modeling Alveolar Soft Part Sarcoma Unveils Novel Mechanisms of Metastasis
- (2016) Miwa Tanaka et al. CANCER RESEARCH
- sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
- (2016) Amanpreet Kaur et al. NATURE
- SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment
- (2016) Y Sun et al. ONCOGENE
- Promoting roles of the secreted frizzled-related protein 2 as a Wnt agonist in lung cancer cells
- (2015) XIAOMIN XIAO et al. ONCOLOGY REPORTS
- Ultrasound Molecular Imaging of Secreted Frizzled Related Protein-2 Expression in Murine Angiosarcoma
- (2014) James K. Tsuruta et al. PLoS One
- Soft Tissue Sarcoma: An Update on Systemic Treatment Options for Patients with Advanced Disease
- (2014) Patrick Schöffski et al. Oncology Research and Treatment
- A Novel Monoclonal Antibody to Secreted Frizzled-Related Protein 2 Inhibits Tumor Growth
- (2013) E. Fontenot et al. MOLECULAR CANCER THERAPEUTICS
- Secreted frizzled-related proteins are required for Wnt/ -catenin signalling activation in the vertebrate optic cup
- (2011) P. Esteve et al. DEVELOPMENT
- The Role of Calcineurin/NFAT in SFRP2 Induced Angiogenesis—A Rationale for Breast Cancer Treatment with the Calcineurin Inhibitor Tacrolimus
- (2011) Sharareh Siamakpour-Reihani et al. PLoS One
- Impaired Wnt Signaling in Embryonal Rhabdomyosarcoma Cells from p53/c-fos Double Mutant Mice
- (2010) Shalini Singh et al. AMERICAN JOURNAL OF PATHOLOGY
- Angiosarcoma
- (2010) Robin J Young et al. LANCET ONCOLOGY
- Oncogenic Functions of Secreted Frizzled-Related Protein 2 in Human Renal Cancer
- (2010) S. Yamamura et al. MOLECULAR CANCER THERAPEUTICS
- Secreted Frizzle-Related Protein 2 Stimulates Angiogenesis via a Calcineurin/NFAT Signaling Pathway
- (2009) A. Courtwright et al. CANCER RESEARCH
- Hemangiomas, Angiosarcomas, and Vascular Malformations Represent the Signaling Abnormalities of Pathogenic Angiogenesis
- (2009) J. Arbiser et al. CURRENT MOLECULAR MEDICINE
- Molecular Characterization of Human Breast Tumor Vascular Cells
- (2008) Rajendra Bhati et al. AMERICAN JOURNAL OF PATHOLOGY
- The anti-apoptotic effect of IGF-1 on tissue resident stem cells is mediated via PI3-kinase dependent secreted frizzled related protein 2 (Sfrp2) release
- (2008) Sebastian Gehmert et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started